Antimicrobial compounds and methods of making and using the same
Abstract
The present refers to the field of antimicrobial compounds and to the methods for preparing and using them. These compounds are useful for treating, preventing, and reducing the risk of microbial infections in humans and animals. Claim 1: A compound characterized in that it has the formula (1), (2), (3) or (4) where -GHJ is selected, alternatively, from -G (HJ) (HJ), where each H and J is selected independently of, CBA-, -DEF, and -GHJ are chemical portions, where A, D, and G are independently selected from the group consisting of: (a) a single bond, (b) C1-8alkyl, (c) C2-8alkenyl, (d) C2-8alkynyl, where i) 0-4 carbon atoms in any of (b) - (d) immediately above, it is optionally replaced by a portion selected from the group consisting of -O-, S (O) p, -NR6-, - (C = O) -, -S (O) pNR6-, -NR6S (O) p -, and -NR6S (O) pNR6-, ii) any of (b) - (d) immediately above, is optionally substituted with one or more R5 groups, and iii) any of (b) - (d) immediately above, it is optionally substituted with C 1-8 -R5 alkyl groups; (e) -O-, (f) -NR6-, (g) -S (O) p-, (h) -C (O) -, (i) -C (O) O-, (j) - OC (O) -, k) -OC (O) O-, (l) -C (O) NR6-, (m) -NR6CO-, (n) -NR6C (O) NR6-, (o) -C (= NR6) -, (p) -C (= NR6) O-, (q) -OC (= NR6) -, (r) -C (= NR6) NR6-, (s) -NR6C (= NR6) -, (t) -C (= S) -, (u) -C (= S) NR6-, (v) -NR6C (= S) -, (w) -C (O) S-, (x) -SC (O) -, (y) -OC (= S) -, (z) -C (= S) O-, (aa) -NR6 (CNR6) NR6-, (bb) -CR6R6C (O) - , (cc) -C (O) NR6 (CR6R6) t-, (dd) a saturated heterocycle, 3-14 membered unsaturated or aromatic containing one or more heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur, or (ee) a 3-14 saturated, unsaturated or aromatic carbocycle, and (ff) - (CR6R6) t -, where (dd) or (ee) is optionally substituted with one or more R5 groups; B, E, and H are independently selected from the group consisting of: (a) a single bond, (b) a 3-14 membered saturated, unsaturated, or aromatic heterocycle containing one or more heteroatoms selected from the group consisting of nitrogen, oxygen, and sulfur, (c) a saturated, unsaturated, or aromatic carbocycle of 3-14 members, where (b) or (c) is optionally substituted with one or more groups (d) C1-8alkyl, (e) C2-8alkenyl, (f) C2-8alkynyl, where i) 0- 4 carbon atoms in any of (d) - (f) immediately above, is optionally replaced by a portion selected from the group consisting of -O-, -S (O) p-, -NR6-, - (C = O) -, -C (= NR6) -, -S (O) pNR6- , -NR6S (O) p-, and -NR6S (O) pNR6-, ii) any of (d) - (f) immediately above is optionally substituted with one or more R5 groups, and iii) any of (d) - (f) immediately above is optionally substituted with C1-8-R5 alkyl groups; and (g) - (CR6R6) t-, C, F, and J are independently selected from the group consisting of: (a) hydrogen, (c) F, (d) CI, (e) Br, (f) I, (g) -CF3, (h) -CN, (i) -N3; (j) -NO2, (k) -NR6 (CR6R6) tR8, (l) -OR8, (m) -S (O) p (CR6R6) tR8, (n) -C (O) (CR6R6) tR8, ( o) -OC (O) (CR6R6) tR8, (p) -SC (O) (CR6R6) tR8, (q) -C (O) O (CR6R6) tR8, (r) -NR6C (O) (CR6R6) tR8, (s) -C (O) NR6 (CR6R6) tR8, (t) -C (= NR6) (CR6R6) tR8, (u) -C (= NNR6R6) (CR6R6) tR8, (v) -C ( = NNR6C (O) R6) (CR6R6) tR8, (w) -C (= NOR8) (CR6R6) tR8, (x) -NR6C (O) O (CR6R6) tR8, (y) -OC (O) NR6 ( CR6R6) tR8, (z) -NR6C (O) NR6 (CR6R6) tR8, (aa) -NR6S (O) p (CR6R6) tR8, (bb) -S (O) pNR6 (CR6R6) tR8, (cc) - NR6S (O) pNR6 (CR6R6) tR8, (dd) -NR6R8, (ee) -NR6 (CR6R6) R8, (ff) -OH, (gg) -NR8R8, (hh) -OCH3, (ii) -S (O) pR8, (jj) -NC (O) R8, (kk) -NR6C (NR6) NR6R8, (ll ) a C1-8 alkyl group, (mm) C2-8 alkenyl group, (nn) C2-8 alkynyl group, (oo) a 3-14 membered saturated, unsaturated or aromatic heterocycle containing one or more heteroatoms selected from the group consisting of in nitrogen, oxygen and sulfur, (pp) a 3-14 membered saturated, unsaturated or aromatic carbocycle, (qq) - (CR6R6) tNR6 (CR6R6) tR8, (rr) -N [(CR6R6) tR8] [C = O (CR6R6) tR8], (ss) - (CR6R6) tN [(CR6R6) tR8] [(CR6R6) tR8], (tt) - (CR6R6) tNR6 (C = O) (CR6R6) tR8, (uu) -haloalkyl, (vv) -C (O) (CR6) [(CR6R6) tR8] R8, (ww) - (CR6R6) tC (O) NR8R8, (xx) - (CR6R6) tC (O) O (CR6R6) tR8, (yy) -NR6C ( O) CR8R8R8, (zz) -N [(CR6R6) tR8] C (O) R8, and (aaa) -S (O) pNR8R8; where (ll) to (pp) are optionally substituted with one or more R7 groups; R5 is selected from (a) hydrogen, (b) F, (c) Cl, (d) Br, (e) I, (f) -CF3, (g) -CN, (h) -N3 (i) - NO2, (j) -NR6R6, (k) -OR8, (l) -NR6 (CNR6) NR6R6, (m) C1-8 alkyl, (n) C1-8 alkenyl, (o) C1-8 alkynyl, (p ) -C1-8alkyl- (a 3-14 membered saturated, unsaturated or aromatic heterocycle containing one or more heteroatoms selected from the group consisting of nitrogen, oxygen, and sulfur), (q) -C1-8alkyl- (carbocycle 3-14 membered saturated, unsaturated or aromatic), (r) -haloalkyl, (s) -SR6, (t) 3-14 membered saturated, unsaturated or aromatic heterocycle containing one or more heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur, and (u) saturated, unsaturated or aromatic carbocycle of 3 -14 members; alternatively, two R5 groups are taken together to form a carbocycle where (m) to (r) and (t) to (u) are optionally substituted with one or more R8; R6 is selected from (a) hydrogen, (b) C1-8alkyl or alternatively two R6 groups are taken together to form a carbocycle, (c) -haloalkyl, (d) a 3-14 membered saturated, unsaturated or aromatic heterocycle containing one or more heteroatoms selected from the group consisting of nitrogen, oxygen, and sulfur, and (e) 3-14 membered saturated, unsaturated, or aromatic carbocycle; where (b) to (e) are optionally substituted with one or more R8; R7 is selected from (a) hydrogen, (b) F, (c) CI, (d) Br, (e) I, (f) -CF3, (g) -CN, (h) -N3, (i) - NO2, (j) -NR6R6, (k) -OR6, (l) -NR6 (CNR6) NR6R6, (m) C1-8 alkyl, (n) C1-8 alkenyl, (o) C1-8 alkynyl, ( p) -C1-8alkyl- (saturated, unsaturated or aromatic 3-14 membered heterocycle containing one or more heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur), (q) C1-8alkyl- (saturated carbocycle , unsaturated or 3-14 membered aromatic), (r) haloalkyl-, (s) -NR6R8, (t) -OR8, (u) - (CR6R6) tNR6R8, (v) -CR6R8R8, (w) -SR6, (x) 3-14 membered saturated, unsaturated or aromatic heterocycle containing one or more heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur, (y) 3-14 membered saturated, unsaturated or aromatic carbocycle, (z) - (CR6R6) tC (O) NR8R8, (aa) -S (O ) pR8, (bb) -NR6C (O) NR6R6, (cc) -NR6C (O) R6, (dd) -C (= NR6) NR6R6; where (m) to (q) and (x) to (y) are optionally substituted with one or more R9; R8 is selected from (a) hydrogen, (b) F, (c) Cl, (d) Br, (e) I, (f) -CF3, (g) -CN, (h) -N3, (i) -NO2, (j) -NR6R9, (k) -OR9, (l) -NR6 (CNR6) NR6R6, (m) C1-8 alkyl, (n) C1-8 alkenyl, (o) C1-8 alkynyl, ( p) -C1-8alkyl- (saturated, unsaturated or aromatic 3-14 membered heterocycle containing one or more heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur), (q) C1-8alkyl- (saturated carbocycle , unsaturated or 3-14 membered aromatic), (r) saturated heterocycle, 3-14 membered unsaturated or aromatic containing one or more heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur, (s) 3-14 membered saturated, unsaturated or aromatic carbocycle, (t) -haloalkyl, (u) -C (O) (CR6R6) tR9, (v) -SR6, (w) -OC (O) (CR6R6) tR9, (x) -NR6C (O) NR6R9, (y) -NR6C (O) R9, ( z) -NR6 (CNR9) (NR6R6), (aa) -ONR6 (CNR6) NR6R6, (bb) -C (= NR9) NR6R6, (cc) -S (O) pR9, (dd) - (CR6R6) tC (O) NR6R9, (ee) - (CR6R6) tOR9, and (ff) - (CR6R6) tNR6R9; where (m) to (s) are optionally substituted with one or more R9; R9 is selected from (a) hydrogen, (b) F, (c) CI, (d) Br, (e) I, (f) -CF3, (g) -CN, (h) -N3, (i) -NO2, (j) -NR6R10, (k) -OR6, (l) -NR6 (CNR6) NR6R6, (m) -C (O) (CR6R6) tNR6R6, (n) C1-8-alkyl, (o) alkenyl C1-8, (p) C1-8 alkynyl, (q) 3-14 membered saturated, unsaturated or aromatic heterocycle containing one or more heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur, (r) saturated carbocycle, 3-14 membered unsaturated or aromatic, (s) -haloalkyl, (t) - (CR6R6) tOR6, (u) -O (CR6R6) tNR6R10, (v) -C (O) R6, (w) -SR6, (x) -C (O) OR10, (y) -S (O) pR6, (z) -C 1-8 alkyl- (3-14 membered saturated, unsaturated or aromatic heterocycle containing one or more heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur), (aa) C1-alkyl -8- (3-14 membered saturated, unsaturated or aromatic carbocycle), (bb) -O (CR6R6) tOR6, (cc) -C (= NR6) NR6R6, (dd) -ONR6R6, (ee) -NR6C ( O) NR6R6, (ff) -O (CR6R6) tOR6, (gg) -NR6C (O) R6, and (hh) - (CR6R6) tNR6R10; where (n) to (r) and (z) to (aa) are optionally substituted with one or more R10; R10 is selected from (a) hydrogen, (b) F, (c) CI, (d) Br, (e) I, (f) -CF3, (g) -CN, (h) -N3, (i) -NO2, (j) -NR6R6, (k) -OR6, (l) -NR6 (CNR6) NR6R6, (m) -C (O) (CR6R6) tNR6R6, (n) C1-8 alkyl, (o) alkenyl C1-8, (p) C1-8 alkynyl, (q) 3-14 membered saturated, unsaturated or aromatic heterocycle containing one or more heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur, (r) saturated carbocycle, 3-14 membered unsaturated or aromatic, (s) -haloalkyl, (t) - (CR6R6) tOR6, (u) -O (CR6R6) tNR6R6, (v) -C (O) R6, (w) -SR6, (x) -C (O) OR6, (y) -S (O) pR6, (z) -C 1-8 alkyl- (3-14 membered saturated, unsaturated or aromatic heterocycle containing one or more heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur), (aa) C1-alkyl -8- (3-14 membered saturated, unsaturated or aromatic carbocycle), (bb) -O (CR6R6) tOR6, (cc) -C (= NR6) NR6R6, (dd) -ONR6R6, (ee) -NR6C ( O) NR6R6, (ff) -O (CR6R6) tOR6, (gg) -NR6C (O) R6, and (hh) - (CR6R6) tNR6R6; optionally, where either the -DEF group or the -GHJ group is absent, but both -DEF and -GHJ are not simultaneously absent; p is 0, 1s 2, and t is 0, 1, 2, or 3, or a salt, ester, tautomer, or prodrug thereof.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
145 members in 20 offices
Priority claims9
| Document | Office | Kind | Date |
|---|---|---|---|
| 25247809 | United States of America | P | |
| 31428710 | United States of America | P | |
| 35820110 | United States of America | P | |
| 61252478 | – | – | – |
| 61314287 | – | – | – |
| 61358201 | – | – | – |
| US20090252478P | – | – | – |
| US20100314287P | – | – | – |
| US20100358201P | – | – | – |
Members145
| Document | Office | Kind | |
|---|---|---|---|
| CA2777734A1 | Canada | A1 | |
| CA2777739A1 | Canada | A1 | |
| CA2777741A1 | Canada | A1 | |
| WO2011047319A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2011047320A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2011047323A2 | World Intellectual Property Organization (WIPO) | A2 | |
| TW201124417A | Taiwan Province of China | A | |
| TW201125564A | Taiwan Province of China | A | |
| TW201125566A | Taiwan Province of China | A | |
| WO2011047319A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO2011047320A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO2011047323A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2011231848A1 | United States of America | A1 | |
| WO2011047319A8 | World Intellectual Property Organization (WIPO) | A8 | |
| AR080558A1 | Argentina | A1 | |
| AR080559A1This record | Argentina | A1 | |
| AR080617A1 | Argentina | A1 | |
| AU2010306646A1 | Australia | A1 | |
| AU2010306647A1 | Australia | A1 | |
| AU2010306650A1 | Australia | A1 | |
| AU2010306647A8 | Australia | A8 | |
| IL219133A0 | Israel | A0 | |
| IL219133D0 | Israel | D0 | |
| IL219134A0 | Israel | A0 | |
| IL219134D0 | Israel | D0 | |
| IL219135A0 | Israel | A0 | |
| IL219135D0 | Israel | D0 | |
| US2012202792A1 | United States of America | A1 | |
| EP2488502A2 | European Patent Office (EPO) | A2 | |
| EP2488525A2 | European Patent Office (EPO) | A2 | |
| EP2488532A2 | European Patent Office (EPO) | A2 | |
| US2012220566A1 | United States of America | A1 | |
| KR20120099435A | Republic of Korea | A | |
| KR20120099436A | Republic of Korea | A | |
| KR20120101392A | Republic of Korea | A | |
| CN102712647A | China | A | |
| CN102712657A | China | A | |
| MX2012004342A | Mexico | A | |
| MX2012004341A | Mexico | A | |
| CN102725274A | China | A | |
| MX2012004340A | Mexico | A | |
| EA201270566A1 | Eurasian Patent Organization (EAPO) | A1 | |
| EA201270568A1 | Eurasian Patent Organization (EAPO) | A1 | |
| EA201270567A1 | Eurasian Patent Organization (EAPO) | A1 | |
| JP2013508297A | Japan | A | |
| JP2013508298A | Japan | A | |
| JP2013508299A | Japan | A | |
| US2013090326A1 | United States of America | A1 | |
| EP2488502A4 | European Patent Office (EPO) | A4 | |
| EP2488532A4 | European Patent Office (EPO) | A4 | |
| EP2488525A4 | European Patent Office (EPO) | A4 | |
| NZ599291A | New Zealand | A | |
| NZ599290A | New Zealand | A | |
| SG10201406631TA | Singapore | A | |
| SG10201406634VA | Singapore | A | |
| SG10201406635QA | Singapore | A | |
| NZ599289A | New Zealand | A | |
| US9009709B2 | United States of America | B2 | |
| US9023843B2 | United States of America | B2 | |
| CN104628729A | China | A | |
| US2015274752A1 | United States of America | A1 | |
| US9193731B2 | United States of America | B2 | |
| US9216979B2 | United States of America | B2 | |
| EA201500913A1 | Eurasian Patent Organization (EAPO) | A1 | |
| US2016031828A1 | United States of America | A1 | |
| US2016031893A1 | United States of America | A1 | |
| MX339000B | Mexico | B | |
| EA023350B1 | Eurasian Patent Organization (EAPO) | B1 | |
| CN105646370A | China | A | |
| NZ623384A | New Zealand | A | |
| TW201622725A | Taiwan Province of China | A | |
| JP2016121171A | Japan | A | |
| JP2016153405A | Japan | A | |
| AU2010306646B2 | Australia | B2 | |
| TW201630914A | Taiwan Province of China | A | |
| JP2016172733A | Japan | A | |
| AU2010306650B2 | Australia | B2 | |
| AU2010306647B2 | Australia | B2 | |
| AU2016231568A1 | Australia | A1 | |
| AU2016231569A1 | Australia | A1 | |
| AU2010306647B9 | Australia | B9 | |
| AU2016266048A1 | Australia | A1 | |
| US9573962B2 | United States of America | B2 | |
| MY161870A | Malaysia | A | |
| NZ713357A | New Zealand | A | |
| BR112012008740A2 | Brazil | A2 | |
| NZ713549A | New Zealand | A | |
| NZ713741A | New Zealand | A | |
| TWI589294B | Taiwan Province of China | B | |
| PH12015502375A1 | Philippines | A1 | |
| PH12015502375B1 | Philippines | B1 | |
| TW201726630A | Taiwan Province of China | A | |
| MX349718B | Mexico | B | |
| PH12016502092A1 | Philippines | A1 | |
| TW201731849A | Taiwan Province of China | A | |
| CN107266470A | China | A | |
| IL219133A | Israel | A | |
| US2017320892A1 | United States of America | A1 | |
| KR20170132900A | Republic of Korea | A | |
| CN107445976A | China | A |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Suspension of granting procedureFB | FB |
Numbers
- Publication, DOCDB
- 080559
- Publication, EPODOC
- AR080559
- Application
- 103805
- Application, DOCDB
- P100103805
- Application, EPODOC
- AR2010P103805
Titles2
- Spanish
- DERIVADOS DE IMIDAZOPIRIMIDINAS, SU USO COMO ANTIMICROBIANOS Y METODOS PARA PREPARARLOS Y UTILIZARLOS
- English
- DERIVATIVES OF IMIDAZOPYRIMIDINES, THEIR USE AS ANTIMICROBIALS AND METHODS TO PREPARE AND USE THEM
Classification
- CPC, 3
- C07D487/04
- C07D491/048
- C07D519/00